Context Therapeutics (CNTX) Return on Capital Employed Growth (1y) (2022 - 2026)
Context Therapeutics (CNTX) Return on Capital Employed Growth (1y) (2022 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
ROCE Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
68,255.00 |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
2,665.00 |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
31,429.00 |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
2,503.00 |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
16,829.00 |
| 10 |
Context Therapeutics |
166.57 Mn |
166.57 Mn |
- |
-4,238.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-4,238.00 |
| Dec 31, 2025 |
-2,686.00 |
| Sep 30, 2025 |
-385.00 |
| Jun 30, 2025 |
-856.00 |
| Mar 31, 2025 |
16,926.00 |
| Dec 31, 2024 |
13,007.00 |
| Sep 30, 2024 |
7,071.00 |
| Jun 30, 2024 |
3,996.00 |
| Mar 31, 2024 |
-14,440.00 |
| Dec 31, 2023 |
-12,173.00 |
| Sep 30, 2023 |
-6,897.00 |
| Jun 30, 2023 |
-4,791.00 |
| Mar 31, 2023 |
-3,103.00 |
| Dec 31, 2022 |
254.00 |
